000			02079 a2200613 4500
005			20250513122834.0
264		0	_c19970807
008			199708s 0 0 eng d
022			_a0090-3493
024	7		_a10.1097/00003246-199707000-00010 _2doi
040			_aNLM _beng _cNLM
100	1		_aOpal, S M
245	0	0	_aConfirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. _h[electronic resource]
260			_bCritical care medicine _cJul 1997
300			_a1115-24 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterleukin 1 Receptor Antagonist Protein
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aReceptors, Interleukin-1 _xantagonists & inhibitors
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aSepsis _xdrug therapy
650	0	4	_aShock, Septic _xdrug therapy
650	0	4	_aSialoglycoproteins _xtherapeutic use
650	0	4	_aSurvival Analysis
700	1		_aFisher, C J
700	1		_aDhainaut, J F
700	1		_aVincent, J L
700	1		_aBrase, R
700	1		_aLowry, S F
700	1		_aSadoff, J C
700	1		_aSlotman, G J
700	1		_aLevy, H
700	1		_aBalk, R A
700	1		_aShelly, M P
700	1		_aPribble, J P
700	1		_aLaBrecque, J F
700	1		_aLookabaugh, J
700	1		_aDonovan, H
700	1		_aDubin, H
700	1		_aBaughman, R
700	1		_aNorman, J
700	1		_aDeMaria, E
700	1		_aMatzel, K
700	1		_aAbraham, E
700	1		_aSeneff, M
773	0		_tCritical care medicine _gvol. 25 _gno. 7 _gp. 1115-24
856	4	0	_uhttps://doi.org/10.1097/00003246-199707000-00010 _zAvailable from publisher's website
999			_c9213916 _d9213916